BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17854770)

  • 1. Potent inhibition of tau fibrillization with a multivalent ligand.
    Honson NS; Jensen JR; Darby MV; Kuret J
    Biochem Biophys Res Commun; 2007 Nov; 363(1):229-34. PubMed ID: 17854770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency of a tau fibrillization inhibitor is influenced by its aggregation state.
    Congdon EE; Necula M; Blackstone RD; Kuret J
    Arch Biochem Biophys; 2007 Sep; 465(1):127-35. PubMed ID: 17559794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors.
    Schafer KN; Murale DP; Kim K; Cisek K; Kuret J; Churchill DG
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3273-6. PubMed ID: 21549596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin B12 Inhibits Tau Fibrillization via Binding to Cysteine Residues of Tau.
    Rafiee S; Asadollahi K; Riazi G; Ahmadian S; Saboury AA
    ACS Chem Neurosci; 2017 Dec; 8(12):2676-2682. PubMed ID: 28841372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases.
    Necula M; Chirita CN; Kuret J
    Biochemistry; 2005 Aug; 44(30):10227-37. PubMed ID: 16042400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-dependent inhibition and reversal of tau filament formation.
    Chirita C; Necula M; Kuret J
    Biochemistry; 2004 Mar; 43(10):2879-87. PubMed ID: 15005623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an intermediate in tau filament formation.
    Chirita CN; Kuret J
    Biochemistry; 2004 Feb; 43(6):1704-14. PubMed ID: 14769048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel fluorescent trimethine cyanine dye 7519 for amyloid fibril inhibition assay.
    Volkova KD; Kovalska VB; Inshin D; Slominskii YL; Tolmachev OI; Yarmoluk SM
    Biotech Histochem; 2011 Jun; 86(3):188-91. PubMed ID: 20210517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggers of full-length tau aggregation: a role for partially folded intermediates.
    Chirita CN; Congdon EE; Yin H; Kuret J
    Biochemistry; 2005 Apr; 44(15):5862-72. PubMed ID: 15823045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation and detection of tau aggregation with small-molecule ligands.
    Chang E; Honson NS; Bandyopadhyay B; Funk KE; Jensen JR; Kim S; Naphade S; Kuret J
    Curr Alzheimer Res; 2009 Oct; 6(5):409-14. PubMed ID: 19874263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tau polymerization with a cyanine dye in two distinct model systems.
    Congdon EE; Figueroa YH; Wang L; Toneva G; Chang E; Kuret J; Conrad C; Duff KE
    J Biol Chem; 2009 Jul; 284(31):20830-9. PubMed ID: 19478088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
    Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
    Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringic acid demonstrates promising protective effect against tau fibrillization and cytotoxicity through regulation of endoplasmic reticulum stress-mediated pathway as a prelude to Alzheimer's disease.
    Li X; Zhang X; Xing R; Qi F; Dong J; Li D; Tian X; Yu B; Huang M; Zhang L; Yuan X; Yang Y; Wu H; Zang L; Mao X; Sui R
    Int J Biol Macromol; 2021 Dec; 192():491-497. PubMed ID: 34599991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of tau aggregation inhibitors for Alzheimer's disease.
    Bulic B; Pickhardt M; Schmidt B; Mandelkow EM; Waldmann H; Mandelkow E
    Angew Chem Int Ed Engl; 2009; 48(10):1740-52. PubMed ID: 19189357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A static laser light scattering assay for surfactant-induced tau fibrillization.
    Necula M; Kuret J
    Anal Biochem; 2004 Oct; 333(2):205-15. PubMed ID: 15450794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for independent mechanisms and a multiple-hit model of tau assembly.
    DeTure M; Granger B; Grover A; Hutton M; Yen SH
    Biochem Biophys Res Commun; 2006 Jan; 339(3):858-64. PubMed ID: 16325769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing Tau Aggregation with Electron Microscopy.
    Huseby CJ; Kuret J
    Methods Mol Biol; 2016; 1345():101-12. PubMed ID: 26453208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular hairpin: a possible model for inhibition of tau aggregation by tannic acid.
    Yao J; Gao X; Sun W; Yao T; Shi S; Ji L
    Biochemistry; 2013 Mar; 52(11):1893-902. PubMed ID: 23442089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of NaCl on the J-aggregation of two thiacarbocyanine dyes in aqueous solutions.
    Xiang J; Yang X; Chen C; Tang Y; Yan W; Xu G
    J Colloid Interface Sci; 2003 Feb; 258(1):198-205. PubMed ID: 12600788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. J-aggregation of anionic ethyl meso-thiacarbocyanine dyes induced by binding to proteins.
    Slavnova TD; Görner H; Chibisov AK
    J Phys Chem B; 2007 Aug; 111(33):10023-31. PubMed ID: 17672494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.